Endocrine manifestations of the rapid-onset obesity with hypoventilation, hypothalamic, autonomic dysregulation, and neural tumor syndrome in childhood

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 10, 2008, Pages 3971-3980

  Bougnères, Pierre ^a   Pantalone, Letitia ^a   Linglart, Agnès ^a   Rothenbühler, Anya ^a   Le Stunff, Catherine ^a  

^a HÔPITAL SAINT VINCENT DE PAUL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GLUCOCORTICOID; SOMATOMEDIN C; THYROTROPIN; THYROXINE;

ADRENAL TUMOR; ARTICLE; AUTONOMIC DYSFUNCTION; CHILD; CLINICAL ARTICLE; COGNITION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CUSHING SYNDROME; DIABETES INSIPIDUS; DISEASE ASSOCIATION; DISEASE COURSE; GANGLIONEUROMA; GROWTH DISORDER; HORMONE DEFICIENCY; HUMAN; HYPERPROLACTINEMIA; HYPOGONADOTROPIC HYPOGONADISM; HYPOPHYSIS ADRENAL SYSTEM; HYPOPITUITARISM; HYPOTHALAMUS DISEASE; HYPOVENTILATION; NERVE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 53749102961     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0238     Document Type: Article

References (64)

1. Amiel J, Laudier B, Attie-Bitach T, Trang H, de Pontual L, Gener B, Trochet D, Etchevers H, Ray P, Simonneau M, Vekemans M, Munnich A, Gaultier C, Lyonnet S 2003 Polyalanine expansion and frameshift mutations of the pairedlike homeobox gene PHOX2B in congenital central hypoventilation syndrome. Nat Genet 33:459-461
2. Sasaki A, Kanai M, Kijima K, Akaba K, Hashimoto M, Hasegawa H, Otaki S, Koizumi T, Kusuda S, Ogawa Y, Tuchiya K, Yamamoto W, Nakamura T, Hayasaka K 2003 Molecular analysis of congenital central hypoventilation syndrome. Hum Genet 114:22-26
3. Weese-Mayer DE, Berry-Kravis EM, Zhou L, Maher BS, Silvestri JM, Curran ME, Marazita ML 2003 Idiopathic congenital central hypoventilation syndrome: analysis of genes pertinent to early autonomic nervous system embryologic development and identification of mutations in PHOX2b. Am J Med Genet A 123:267-278
4. Matera I, Bachetti T, Puppo F, Di Duca M, Morandi F, Casiraghi GM, Cilio MR, Hennekam R, Hofstra R, Schober JG, Ravazzolo R, Ottonello G, Ceccherini I 2004 PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. J Med Genet 41:373-380
5. Trochet D, O'Brien LM, Gozal D, Trang H, Nordenskjold A, Laudier B, Svensson PJ, Uhrig S, Cole T, Niemann S, Munnich A, Gaultier C, Lyonnet S, Amiel J 2005 PHOX2B genotype allows for prediction of tumor risk in congenital central hypoventilation syndrome. Am J Hum Genet 76:421-426
6. Berry-Kravis EM, Zhou L, Rand CM, Weese-Mayer DE 2006 Congenital central hypoventilation syndrome: PHOX2B mutations and phenotype. Am J Respir Crit Care Med 174:1139-1144
7. Fishman LS, Samson JH, Sperling DR 1965 Primary alveolar hypoventilation syndrome (Ondine's curse). Am J Dis Child 110:155-161
8. Ize-Ludlow D, Gray JA, Sperling MA, Berry-Kravis EM, Milunsky JM, Farooqi IS, Rand CM, Weese-Mayer DE 2007 Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation presenting in childhood. Pediatrics 120:e179-e188
9. Katz ES, McGrath S, Marcus CL 2000 Late-onset central hypoventilation with hypothalamic dysfunction: a distinct clinical syndrome. Pediatr Pulmonol 29:62-68
10. Dunger DB, Leonard JV, Wolff OH, Preece MA 1980 Effect of naloxone in a previously undescribed hypothalamic syndrome. A disorder of the endogenous opioid peptide system? Lancet 1:1277-1281
11. Frank Y, Kravath RE, Inoue K, Hirano A, Pollak CP, Rosenberg RN, Weitzman ED 1981 Sleep apnea and hypoventilation syndrome associated with acquired nonprogressive dysautonomia: clinical and pathological studies in a child. Ann Neurol 10:18-27
12. duRivage SK, Winter RJ, Brouillette RT, Hunt CE, Noah Z 1985 Idiopathic hypothalamic dysfunction and impaired control of breathing. Pediatrics 75: 896-898
13. Proulx F, Weber ML, Collu R, Lelievre M, Larbrisseau A, Delisle M 1993 Hypothalamic dysfunction in a child: a distinct syndrome? Report of a case and review of the literature. Eur J Pediatr 152:526-529
14. North KN, Ouvrier RA, McLean CA, Hopkins IJ 1994 Idiopathic hypothalamic dysfunction with dilated unresponsive pupils: report of two cases. J Child Neurol 9:320-325
15. Ouvrier R, Nunn K, Sprague T, McLean C, Arbuckle S, Hopkins I, North K 1995 Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome? Lancet 346:1298
16. Del Carmen Sanchez M, Lopez-Herce J, Carrillo A, Moral R, Arias B, Rodriguez A, Sancho L 1996 Late onset central hypoventilation syndrome. Pediatr Pulmonol 21:189-191
17. Gothi D, Joshi JM 2005 Late onset hypoventilation syndrome: is there a spectrum of idiopathic hypoventilation syndromes? Indian J Chest Dis Allied Sci 47:293-297
18. Weese-Mayer DE, Silvestri JM, Huffman AD, Smok-Pearsall SM, Kowal MH, Maher BS, Cooper ME, Marazita ML 2001 Case/control family study of autonomic nervous system dysfunction in idiopathic congenital central hypoventilation syndrome. Am J Med Genet 100:237-245
19. 1999 Idiopathic congenital central hypoventilation syndrome: diagnosis and management. American Thoracic Society. Am J Respir Crit Care Med 160:368-373
20. O'Rahilly S, Farooqi IS 2006 Genetics of obesity. Philos Trans R Soc Lond B Biol Sci 361:1095-1105
21. Williams T, Berelowitz M, Joffe SN, Thorner MO, Rivier J, Vale W, Frohman LA 1984 Impaired growth hormone responses to growth hormone-releasing factor in obesity. A pituitary defect reversed with weight reduction. N Engl J Med 311:1403-1407
22. Reinehr T, de Sousa G, Andler W 2006 Hyperthyrotropinemia in obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab 91:3088-3091
23. Mitchell RB, Kelly J 2007 Outcome of adenotonsillectomy for obstructive sleep apnea in obese and normal-weight children. Otolaryngol Head Neck Surg 137:43-48
24. Robyn JA, Koch CA, Montalto J, Yong A, Warne GL, Batch JA 1997 Cushing's syndrome in childhood and adolescence. J Paediatr Child Health 33:522-527
25. Batista DL, Riar J, Keil M, Stratakis CA 2007 Diagnostic tests for children who are referred for the investigation of Cushing syndrome. Pediatrics 120:e575-e586
26. Sutter JA, Grimberg A 2006 Adrenocortical tumors and hyperplasias in childhood-etiology, genetics, clinical presentation and therapy. Pediatr Endocrinol Rev 4:32-39
27. Le Stunff C, Dechartres A, Mariot V, Lotton C, Trainor C, Miraglia Del Giudice E, Meyre D, Bieche I, Laurendeau I, Froguel P, Zelenika D, Fallin D, Lathrop M, Romeo PH, Bougneres P 2008 Association analysis indicates that a variant GATA-binding site in the PIK3CB promoter is a Cis-acting expression quantitative trait locus for this gene and attenuates insulin resistance in obese children. Diabetes 57:494-502
28. Coutant R, Lahlou N, Bouvattier C, Bougneres P 1998 Circulating leptin level and growth hormone response to stimulation tests in obese and normal children. Eur J Endocrinol 139:591-597
29. Bouvattier C, Lahlou N, Roger M, Bougneres P 1998 Hyperleptinaemia is associated with impaired gonadotrophin response to GnRH during late puberty in obese girls, not boys. Eur J Endocrinol 138:653-658
30. Dos Santos C, Fallin D, Le Stunff C, LeFur S, Bougneres P 2004 INS VNTR is a QTL for the insulin response to oral glucose in obese children. Physiol Genomics 16:309-313
31. Le Stunff C, Le Bihan C, Schork NJ, Bougneres P 2000 A common promoter variant of the leptin gene is associated with changes in the relationship between serum leptin and fat mass in obese girls. Diabetes 49:2196-2200
32. Assie G, Bahurel H, Coste J, Silvera S, Kujas M, Dugue MA, Karray F, Dousset B, Bertherat J, Legmann P, Bertagna X 2007 Corticotroph tumor progression after adrenalectomy in Cushing's disease: a reappraisal of Nelson's syndrome. J Clin Endocrinol Metab 92:172-179
33. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
34. Anouar Y, Yon L, Guillemot J, Thouennon E, Barbier L, Gimenez-Roqueplo AP, Bertherat J, Lefebvre H, Klein M, Muresan M, Grouzmann E, Plouin PF, Vaudry H, Elkahloun AG 2006 Development of novel tools for the diagnosis and prognosis of pheochromocytoma using peptide marker immunoassay and gene expression profiling approaches. Ann NY Acad Sci 1073:533-540
35. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M 2003 Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593-5602
36. Lonergan GJ, Schwab CM, Suarez ES, Carlson CL 2002 Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics 22:911-934
37. Scherer A, Niehues T, Engelbrecht V, Modder U 2001 Imaging diagnosis of retroperitoneal ganglioneuroma in childhood. Pediatr Radiol 31:106-110
38. Radin R, David CL, Goldfarb H, Francis IR 1997 Adrenal and extra-adrenal retroperitoneal ganglioneuroma: imaging findings in 13 adults. Radiology 202:703-707
39. Johnson GL, Hruban RH, Marshall FF, Fishman EK 1997 Primary adrenal ganglioneuroma: CT findings in four patients. AJR Am J Roentgenol 169:169-171
40. Ichikawa T, Ohtomo K, Araki T, Fujimoto H, Nemoto K, Nanbu A, Onoue M, Aoki K 1996 Ganglioneuroma: computed tomography and magnetic resonance features. Br J Radiol 69:114-121
41. Serra AD, Rafal RB, Markisz JA 1992 MRI characteristics of two cases of adrenal ganglioneuromas. Clin Imaging 16:37-39
42. Geoerger B, Hero B, Harms D, Grebe J, Scheidhauer K, Berthold F 2001 Metabolic activity and clinical features of primary ganglioneuromas. Cancer 91:1905-1913
43. Cohen LE, Wondisford FE, Salvatoni A, Maghnie M, Brucker-Davis F, Weintraub BD, Radovick S 1995 A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J Clin Endocrinol Metab 80:679-684
44. Reiter EO RR 2003 Normal and aberrant growth. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS, eds. Williams textbook of endocrinology. 10th ed. Philadelphia: Saunders
45. De Simone M, Farello G, Palumbo M, Gentile T, Ciuffreda M, Olioso P, Cinque M, De Matteis F 1995 Growth charts, growth velocity and bone development in childhood obesity. Int J Obes Relat Metab Disord 19:851-857
46. Falorni A, Bini V, Cabiati G, Papi F, Arzano S, Celi F, Sanasi M 1997 Serum levels of type I procollagen C-terminal propeptide, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 in obese children and adolescents: relationship to gender, pubertal development, growth, insulin, and nutritional status. Metabolism 46:862-871
47. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S 1997 Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903-908
48. Strobel A, Issad T, Camoin L, Ozata M, Strosberg AD 1998 A leptin missense mutation associated with hypogonadism and morbid obesity. Nat Genet 18: 213-215
49. Ozata M, Ozdemir IC, Licinio J 1999 Human leptin deficiency caused by a missense mutation: multiple endocrine defects, decreased sympathetic tone, and immune system dysfunction indicate new targets for leptin action, greater central than peripheral resistance to the effects of leptin, and spontaneous correction of leptin-mediated defects. J Clin Endocrinol Metab [Erratum (2000) 85:416] 84:3686-3695
50. Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B 1998 A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398-401
51. Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A 1998 Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155-157
52. Jackson RS, Creemers JW, Ohagi S, Raffin-Sanson ML, Sanders L, Montague CT, Hutton JC, O'Rahilly S 1997 Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene. Nat Genet 16:303-306
53. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O'Rahilly S 2003 Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med 348:1085-1095
54. Yeo GS, Connie Hung CC, Rochford J, Keogh J, Gray J, Sivaramakrishnan S, O'Rahilly S, Farooqi IS 2004 A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat Neurosci 7:1187-1189
55. Goto S, Umehara S, Gerbing RB, Stram DO, Brodeur GM, Seeger RC, Lukens JN, Matthay KK, Shimada H 2001 Histopathology (International Neuroblastoma Pathology Classification) and MYCN status in patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 92: 2699-708
56. Davies RP, Slavotinek JP, Dorney SF 1990 VIP secreting tumours in infancy. A review of radiological appearances. Pediatr Radiol 20:504-508
57. Sirvent N, Berard E, Chastagner P, Feillet F, Wagner K, Sommelet D 2003 Paraneoplastic syndrome? Med Pediatr Oncol 40:326-328
58. Nunn K, Ouvrier R, Sprague T, Arbuckle S, Docker M 1997 Idiopathic hypothalamic dysfunction: a paraneoplastic syndrome? J Child Neurol 12:276-281
59. Teinturier C, Pauchard MS, Brugieres L, Landais P, Chaussain JL, Bougneres PF 1999 Clinical and prognostic aspects of adrenocortical neoplasms in childhood. Med Pediatr Oncol 32:106-111
60. Gunther DF, Bourdeau I, Matyakhina L, Cassarino D, Kleiner DE, Griffin K, Courkoutsakis N, Abu-Asab M, Tsokos M, Keil M, Carney JA, Stratakis CA 2004 Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity? J Clin Endocrinol Metab 89:3173-3182
61. Camfferman D, Lushington K, O'Donoghue F, Doug McEvoy R 2006 Obstructive sleep apnea syndrome in Prader-Willi Syndrome: an unrecognized and untreated cause of cognitive and behavioral deficits? Neuropsychol Rev 16:123-129
62. Festen DA, de Weerd AW, van den Bossche RA, Joosten K, Hoeve H, Hokken-Koelega AC 2006 Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J Clin Endocrinol Metab 91:4911-4915
63. Karavanaki K, Divoli A, Dattani M, Briassoulis G, Theodorou V, Hatzara V, Avlonitis S 2002 Multiple pituitary hormone abnormalities, fever, behavioral problems, seizures and apnoic spells in a 6-year old girl. Hormones (Athens) 1:121-125
64. Batista D, Courkoutsakis NA, Oldfield EH, Griffin KJ, Keil M, Patronas NJ, Stratakis CA 2005 Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with Cushing disease. J Clin Endocrinol Metab 90:5134-5140